US Senators Question Leading Labs’ Capacity To Process Enough COVID-19 Tests To Slow Pandemic
Quest Diagnostics, Mayo Clinic, LabCorp, Bioreference and ARUP Labs must now answer to Sens. Elizabeth Warren and Tina Smith
Two Senate Democrats sent letters to five well-known US testing laboratories, questioning their ability to process sufficient COVID-19 tests.
You may also be interested in...
To better control a possible secondary wave of coronavirus cases over the summer as some state governors reopen their economies for businesses, US federal agencies are working with test and medical supply manufacturers to expand capacity, officials told Congress.
The US Medicare agency introduced a new end-stage renal disease treatment model on Friday to incentivize use of home dialysis.
In a 15 September update of adverse events from Bayer’s now-defunct Essure birth control device, the US agency tallies patients’ unwanted pregnancies and describes serious injuries.